|
|
The capital raising landscape and lessons learnedSpotlight on gene and cell therapy as an innovative and evolving technology areaCapitalizing on the commercial potential of direct-to-consumer genetic testingStrategies for operationalizing a personalized medicine program at the point of careThe promise behind AI for discovery, validation, diagnosis, and data sharingEvolving business models for companion diagnostics |
Ampersand Capital Partners
|
Sharing Their Knowledge With Others